MGH-led study retrospectively analyzed 5,000 radiologist-reviewed screening exams using the company’s Genius AI® Detection Solution MARLBOROUGH, MA – Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of… Read More
VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize drug delivery for applications with significant… Read More
GARCHING/MUNICH, DE & VANCOUVER, BC – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical-stage biotechnology company advancing a distinctive portfolio of differentiated and… Read More
VANCOUVER, BC – Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners’ clinical development, announced two poster presentations and one oral presentation highlighting… Read More
Dosing underway in Phase 1 clinical trial for ABD-147 (DLL3-targeting radiopharmaceutical) in patients with extensive stage small cell lung cancer and large cell neuroendocrine carcinoma of the lung; Abdera to present… Read More
